Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-04
DOI
10.1038/s41419-020-2509-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma
- (2019) Jiajia He et al. CANCER LETTERS
- Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints
- (2019) Audrey LEQUEUX et al. CANCER LETTERS
- FAK and β‐Catenin Cooperate to Induce Hepatocellular Carcinoma
- (2019) Shang Na et al. HEPATOLOGY
- The Mutational Features of Aristolochic Acid–Induced Mouse and Human Liver Cancers
- (2019) Zhao‐Ning Lu et al. HEPATOLOGY
- Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis
- (2019) Jingxiao Wang et al. JOURNAL OF HEPATOLOGY
- Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
- (2019) Shuzhen Chen et al. CANCER LETTERS
- Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma
- (2018) Margaret A Hill et al. CANCER RESEARCH
- Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
- (2018) Dirk J. van der Windt et al. HEPATOLOGY
- cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
- (2018) Elizabeth Brunt et al. HEPATOLOGY
- Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice
- (2018) Jingxiao Wang et al. ONCOGENE
- Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
- (2018) Mingjie Dong et al. Cell Death & Disease
- Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
- (2018) Anqiang Wang et al. Nature Communications
- Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment
- (2018) Chien-Chi Lin et al. CANCER LETTERS
- FBXW7: a critical tumor suppressor of human cancers
- (2018) Chien-Hung Yeh et al. Molecular Cancer
- Necroptosis microenvironment directs lineage commitment in liver cancer
- (2018) Marco Seehawer et al. NATURE
- De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation
- (2018) Johanna R. Schaub et al. NATURE
- Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma
- (2018) Meng Sha et al. Cancer Medicine
- Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma
- (2017) Xiao-fang Zhang et al. HUMAN PATHOLOGY
- The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis
- (2017) Lingling Ou et al. International Journal of Nanomedicine
- Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
- (2017) Agrin Moeini et al. JOURNAL OF HEPATOLOGY
- Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma
- (2016) Xueru Mu et al. GASTROENTEROLOGY
- Differential requirement forde novolipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
- (2016) Lei Li et al. HEPATOLOGY
- Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype
- (2016) Matthias S. Matter et al. HEPATOLOGY
- Monocytes promote liver carcinogenesis in an oncogene-specific manner
- (2016) Vladislava Juric et al. JOURNAL OF HEPATOLOGY
- Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
- (2016) Lei Li et al. JOURNAL OF HEPATOLOGY
- Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics
- (2016) John R. Bergquist et al. HPB
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions
- (2015) Xi Chen et al. CANCER SCIENCE
- LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours
- (2015) Anthony J Scarzello et al. GUT
- Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy
- (2015) Hye-Lim Ju et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
- (2015) Xueru Mu et al. JOURNAL OF CLINICAL INVESTIGATION
- Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons
- (2015) Houbo Jiang et al. Nature Communications
- Contributions of Hepatocytes and Bile Ductular Cells in Ductular Reactions and Remodeling of the Biliary System after Chronic Liver Injury
- (2014) Yasuharu Nagahama et al. AMERICAN JOURNAL OF PATHOLOGY
- Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
- (2014) Xin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice
- (2014) Junyan Tao et al. GASTROENTEROLOGY
- FAK Is required for c-Met/β-catenin-driven hepatocarcinogenesis
- (2014) Na Shang et al. HEPATOLOGY
- Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma
- (2014) Kangsheng Tu et al. Molecular Cancer
- Robust cellular reprogramming occurs spontaneously during liver regeneration
- (2013) K. Yanger et al. GENES & DEVELOPMENT
- Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma
- (2013) Engin Gürlevik et al. HEPATOLOGY
- Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis
- (2013) Wan-Ting Chen et al. HEPATOLOGY
- Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
- (2013) Waraporn Chan-on et al. NATURE GENETICS
- Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice
- (2013) H Ye et al. ONCOGENE
- Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
- (2013) Hye-Lim Ju et al. PLoS One
- Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways
- (2012) Cédric Coulouarn et al. CARCINOGENESIS
- Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation
- (2012) Sarah–Fee Katz et al. GASTROENTEROLOGY
- A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition
- (2012) Jae Yeon Seok et al. HEPATOLOGY
- Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
- (2012) Edward Kai-Hua Chow et al. HEPATOLOGY
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
- (2012) Sayaka Sekiya et al. JOURNAL OF CLINICAL INVESTIGATION
- Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways
- (2012) Chunmei Wang et al. JOURNAL OF HEPATOLOGY
- Bmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development
- (2012) Lingling Fan et al. PLoS One
- Coactivation of AKT and -Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
- (2011) J. K. Stauffer et al. CANCER RESEARCH
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2,
- (2011) Coral Ho et al. HEPATOLOGY
- The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular-Cholangiocarcinoma
- (2010) C. Panjala et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
- (2009) Johannes Haybaeck et al. CANCER CELL
- Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage
- (2009) Naiara Beraza et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A systems biology perspective on cholangiocellular carcinoma development: Focus on MAPK-signaling and the extracellular environment
- (2009) Chunxia Wang et al. JOURNAL OF HEPATOLOGY
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
- (2009) Ledu Zhou et al. MEDICAL ONCOLOGY
- Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis
- (2009) C.-R. Xu et al. MOLECULAR CANCER RESEARCH
- Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
- (2009) S. Inokuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression
- (2008) A. Suzuki et al. DEVELOPMENT
- A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver
- (2008) Kirk J. Wangensteen et al. HEPATOLOGY
- Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways
- (2008) Carl F. Ware IMMUNOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now